August 22, 2017 / 4:22 AM / 3 months ago

BRIEF-CSPC Pharmaceutical Group says HY revenue was HK$7.20 bln

Aug 22 (Reuters) - CSPC Pharmaceutical Group Ltd:

* HY total revenue HK$7.20 billion versus HK$6.15 billion

* Do not declare payment of an interim dividend for six months ended 30 june 2017

* HY profit attributable to shareholders HK$1.31 billion versus HK$1.03 billion Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below